THLD 1.30-1.50 Annotated chart and insider buys. volume tiny on the move down and short interest under 1mln (ie low) Pancreatic cancer targetted. Insiders participated BIG in the march placement. Mostly at 2.05. Very confident sign. Pipeline timelines http://www.thresholdpharm.com/sec/clinical_pipeline First clinical IIb results due late 2011 (actual data release after being processed) images.investorshub.advfn.com/images/uploads/2011/8/10/ckffqTHLD_insiders.JPG Daily chart(annotated and self updating) stockcharts.com/c-sc/sc?s=THLD&p=D&b=5&g=0&i=p71162441008&a=236295761&r=9873